Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limitedverified

3692.HK

Price:

$38.54

Market Cap:

$207.27B

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, and metabolic diseases. Its principal products include Mailingda, a drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Oulanning, Ameining, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, and Ruibote drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Sc...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2019-06-14

Stock Exchange

HKSE

Ticker

3692.HK

The Enterprise Value as of December 2025 (TTM) for Hansoh Pharmaceutical Group Company Limited (3692.HK) is 180.29B

According to Hansoh Pharmaceutical Group Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 180.29B. This represents a change of 104.05% compared to the average of 88.35B of the last 4 quarters.

Hansoh Pharmaceutical Group Company Limited (3692.HK) Historical Enterprise Value (quarterly & annually)

How has 3692.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Hansoh Pharmaceutical Group Company Limited over the last ten years is 97.62B. The current 180.29B Enterprise Value has changed 18.37% with respect to the historical average. Over the past ten years (40 quarters), 3692.HK's Enterprise Value was at its highest in in the June 2020 quarter at 188.54B. The Enterprise Value was at its lowest in in the January 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

97.62B

Median

92.29B

Minimum

64.28B

Maximum

181.69B

Hansoh Pharmaceutical Group Company Limited (3692.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hansoh Pharmaceutical Group Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 53.32%

Maximum Annual Enterprise Value = 181.69B

Minimum Annual Increase = -55.56%

Minimum Annual Enterprise Value = 64.28B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202473.74B3.23%
202371.43B11.12%
202264.28B-20.39%
202180.75B-55.56%
2020181.69B53.32%
2019118.50B22.74%
201896.55B4.62%
201792.29B-7.11%

Hansoh Pharmaceutical Group Company Limited (3692.HK) Average Enterprise Value

How has 3692.HK Enterprise Value performed in the past?

The current Enterprise Value of Hansoh Pharmaceutical Group Company Limited (3692.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

69.82B

5-year avg

94.38B

10-year avg

97.62B

Hansoh Pharmaceutical Group Company Limited (3692.HK) Enterprise Value vs. Peers

How is 3692.HK’s Enterprise Value compared to its peers?

Hansoh Pharmaceutical Group Company Limited’s Enterprise Value is greater than JD Health International Inc. (140.89B), greater than WuXi Biologics (Cayman) Inc. (122.53B), greater than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (97.48B), greater than Innovent Biologics, Inc. (123.34B), less than WuXi AppTec Co., Ltd. (214.51B), greater than Sino Biopharmaceutical Limited (106.98B), greater than China Medical System Holdings Limited (26.36B), greater than Grand Pharmaceutical Group Limited (33.66B), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (48.90B), greater than China Resources Pharmaceutical Group Limited (100.49B),

Build a custom stock screener for Hansoh Pharmaceutical Group Company Limited (3692.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansoh Pharmaceutical Group Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hansoh Pharmaceutical Group Company Limited (3692.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hansoh Pharmaceutical Group Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hansoh Pharmaceutical Group Company Limited's Enterprise Value?

What is the highest Enterprise Value for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

What is the 3-year average Enterprise Value for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

What is the 5-year average Enterprise Value for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

How does the current Enterprise Value for Hansoh Pharmaceutical Group Company Limited (3692.HK) compare to its historical average?